The additive role of angiogenic markers for women with confirmed preeclampsia-Reference-Cited by-同舟云学术

The additive role of angiogenic markers for women with confirmed preeclampsia

Published:2023-05 Issue:5 Volume:228 Page:573.e1-573.e11
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Suresh Sunitha,Patel Easha,Mueller Ariel,Morgan Jessica,Lewandowski Whitney Lynn,Verlohren Stefan,von Dadelszen Peter,Magee Laura A.,Rana Sarosh^ORCID

Funder

Siemens

Beckman Coulter Foundation

Roche

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference34 articles.

1. The global impact of pre-eclampsia and eclampsia;Duley;Semin Perinatol,2009

2. Preeclampsia: short-term and long-term implications;Pauli;Obstet Gynecol Clin North Am,2015

3. Angiogenic biomarkers for risk stratification in women with preeclampsia;Docheva;Clin Chem,2022

4. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia;Levine;N Engl J Med,2006

5. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia;Maynard;J Clin Invest,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive status;AJOG Global Reports;2024-08

3. Clinical utility of angiogenic biomarkers;AM J OBSTET GYNECOL;2024

4. Optimal antenatal corticosteroids timing in women with nonsevere preeclampsia;American Journal of Obstetrics and Gynecology;2024-06

5. Clinical utility of angiogenic biomarkers;American Journal of Obstetrics and Gynecology;2024-06